Prevention of Asthma Relapse After Discharge From Emergency

Phase 3

Completed

• Conditions: Asthma

• Registration Number: NCT00326053
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2006-05
• Study First Submitted: 2006-05-12
• Study First Submitted QC: 2006-05-12
• Study First Posted: 2006-05-16
• Study Completion: 2007-05
• Status Verified: 2011-01
• Last Update Submitted: 2011-01-21
• Last Update Posted: 2011-01-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• 18 - 65 years of age
• Presenting at a study emergency department with an asthma exacerbation

Read More

Exclusion Criteria

• Admission to hospital
• Patients receiving more than 2000 µg/day of beclomethasone equivalent inhaled corticosteroids (1000 µg/day fluticasone or 1600 µg/day budesonide)

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Time to first asthma relapse

Secondary Outcome Measures

Name	Time	Method
Complete AE and SAE collection
Mean use of reliever medication
Asthma Control Questionnaire (ACQ) score

Trial Locations

Locations (1)

Research Site; 🇨🇦 Quebec, Canada